Compare CNTX & DOMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTX | DOMH |
|---|---|---|
| Founded | 2015 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.7M | 53.1M |
| IPO Year | 2021 | 2010 |
| Metric | CNTX | DOMH |
|---|---|---|
| Price | $0.32 | $2.03 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $4.03 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 267.3K |
| Earning Date | 11-04-2026 | 11-09-2026 |
| Dividend Yield | N/A | ★ 45.84% |
| EPS Growth | 17.39 | ★ 34.03 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $123,104,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 578.41 |
| 52 Week Low | $0.30 | $1.91 |
| 52 Week High | $3.62 | $6.77 |
| Indicator | CNTX | DOMH |
|---|---|---|
| Relative Strength Index (RSI) | 35.78 | 37.41 |
| Support Level | N/A | $1.91 |
| Resistance Level | $0.40 | $3.39 |
| Average True Range (ATR) | 0.03 | 0.21 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 23.19 | 2.90 |
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
Dominari Holdings Inc is a holding company that, through its various subsidiaries, is engaged in wealth management, investment banking, sales and trading, asset management, and insurance. In addition to capital investment, Dominari provides management support to the executive teams of its subsidiaries, helping them to operate efficiently and reduce costs under a streamlined infrastructure. The Company operates in two reportable business segments: Dominari Financial and Legacy AIkido, with the majority of revenue from Dominari Financial.